The Antitrust Review of the Americas 2017

United States: Pharmaceutical Antitrust

The past year has seen an increase in US case law developments in the area of pharmaceutical antitrust. This chapter focuses on the four types of pharmaceutical antitrust cases that have been most active:

Interested in becoming a GCR author? Please contact our Insight Manager.

Get in touch